PPD Stock

PPD Shares Outstanding

Delisted

The The number of shares of PPD (PPD) as of Sep 5, 2026 is 350.13 M. In the previous year, The number of shares was 350.13 M — a change of 0.00% (lower).

Shares Outstanding

350.13 M

YoY

0.00%

Last updated:

In 2026, PPD had 350.13 M outstanding stocks, a 0.00% change from the 350.13 M stocks in the previous year.

The PPD Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2018
350.13 M USD
Jan 1, 2019
350.13 M USD
Jan 1, 2020
350.13 M USD
Jan 1, 2021 (e)
347.00 USD
Jan 1, 2022 (e)
347.00 USD
Jan 1, 2023 (e)
347.00 USD
Jan 1, 2024 (e)
347.00 USD
Jan 1, 2025 (e)
347.00 USD
The PPD Shares Outstanding history
YEARShares OutstandingYoY
est347.000.00%
est347.000.00%
est347.000.00%
est347.000.00%
est347.00-100.00%
350.13 M0.00%
350.13 M0.00%
350.13 M0.00%
350.13 M0.00%
350.13 M
Access this data via the Eulerpool API

PPD Number of shares

PPD shares outstanding

The number of shares of PPD was 347 M in 2025. This indicates how many shares PPD is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
279.00 M Stocks
Jan 1, 2019
281.00 M Stocks
Jan 1, 2020
347.00 M Stocks
Jan 1, 2021 (e)
347.00 M Stocks
Jan 1, 2022 (e)
347.00 M Stocks
Jan 1, 2023 (e)
347.00 M Stocks
Jan 1, 2024 (e)
347.00 M Stocks
Jan 1, 2025 (e)
347.00 M Stocks

PPD Stock analysis

What does PPD do? PPD Inc is a global company for medical research and services that was founded in 1985 and is headquartered in Wilmington, North Carolina, USA. The company is known for its ability to conduct clinical trials and develop research programs for the biopharmaceutical and medical industry. PPD is a leading provider of comprehensive, integrated services for phases I-IV of clinical research, from non-interventional studies to contract research for pharmaceutical and biotech clients. PPD's business model is based on three key pillars to provide customers with a broad portfolio of services: the first pillar is comprehensive clinical research required for drug registration with regulatory authorities, the second pillar focuses on providing research-based data and analytical methods to facilitate decision-making and risk assessment in the healthcare sector, and the third pillar encompasses extensive laboratory analyses and diagnostic tests to improve patient health and support research efforts. PPD has multiple divisions focused on specific markets and customers. The Clinical Trials division offers services for drug development up to approval by regulatory authorities, including the setup and monitoring of clinical trials and statistical analysis of test results. The Data Management division provides data capture and management solutions for clinical trials to ensure high data quality and compliance with regulations. The Medical Monitoring division offers medical consultation and monitoring during clinical trials. PPD also has a division for Real World Evidence studies, which collects data from routine clinical practice to assess the safety and efficacy of drugs. PPD has made some important acquisitions in the past to strengthen its presence in the industry. In 2011, PPD was acquired by private equity firms Carlyle Group and Hellman & Friedman, becoming a private company. In 2020, PPD went public. In 2018, PPD acquired Evidera, a company specializing in clinical epidemiology and outcomes research. In 2019, PPD acquired Q-Squared Solutions, expanding its extensive laboratory analysis and diagnostic testing capabilities. PPD's offerings include a wide range of products and services, including unique planning and implementation solutions that enable efficient conduct of clinical trials. These solutions also include electronic data capture and management systems, as well as statistical analysis tools. PPD also offers specialized services, such as training programs for clinical investigators and staff. PPD aims to enable safe, faster, and cost-effective drug development through clinical research. In the future, PPD will continue to expand its business model and services to meet the needs of its customers in the changing industry and support innovative research programs. PPD is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating PPD's Shares Outstanding

PPD's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in PPD’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding PPD’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in PPD’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about PPD stock

The number of shares of PPD is 350.13 M in 2026.

The number of shares of PPD changed from 350.13 M to 350.13 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares PPD since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

Other — PPD

All Key Metrics — PPD